by Daniel Webster, dWeb.News Editor
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(r) brand of products, today announced that management will present at the virtual 45th Nasdaq Investor Conference on Friday, December 3, 2021 at 11: 30 a.m. (Eastern Time).
To listen to the live webcast of the presentation, please visit investors.insulet.com/events. After the event, a replay of the webcast is available.
About Insulet Corporation.
Insulet Corporation, NASDAQ: PODD, is a Massachusetts-based medical device company that aims to make life easier for people living with diabetes and other conditions. The Omnipod Insulin Management System is a novel alternative to traditional insulin delivery methods. The disposable Pod is easy to wear and provides non-stop insulin delivery for up to three days without the need to use a needle. Insulet leverages its unique design by adapting its Omnipod technology platform to deliver non-insulin subcutaneous drug across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.
More dWeb.News Business News at https://dweb.news/category/dweb-news/section-b-business-news/
The post BUSINESS: Insulet To Attend Nasdaq’s 45th Investor Conference appeared first on dWeb.News dWeb.News from Daniel Webster Publisher dWeb.News – dWeb Local Tech News and Business News